Literature DB >> 6445503

Biochemistry of muscle membranes in Duchenne muscular dystrophy.

L P Rowland.   

Abstract

In Duchenne muscular dystrophy, as in other genetic diseases, there must be a biochemical abnormality. This fundamental genetic fault has not been identified, but several indirect lines of evidence suggest that the surface membranes of skeletal muscle are affected. The biochemical evidence implies abnormal egress of soluble enzymes and other proteins from muscle, abnormal permeability, and altered properties of membrane-bound enzymes. As a result of the presumed genetic abnormality, functional properties are altered, and impaired regulation of intracellular calcium content could be responsible for the hallmarks of the disease--progressive weakness and degeneration of muscle. The evidence is by no means conclusive, however, and some of it is contradictory. Technical advances must be made before isolated membranes can be characterized biochemically. Other theories are also being evaluated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6445503     DOI: 10.1002/mus.880030103

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  38 in total

Review 1.  Exercise-induced muscle damage and adaptation.

Authors:  C B Ebbeling; P M Clarkson
Journal:  Sports Med       Date:  1989-04       Impact factor: 11.136

Review 2.  Ionic transporting systems of skeletal muscle in relation with innervation and their involvement in myotonic diseases.

Authors:  J F Renaud
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

3.  Voltage-dependent channels of human muscle cultures.

Authors:  A Trautmann; C Delaporte; A Marty
Journal:  Pflugers Arch       Date:  1986-02       Impact factor: 3.657

4.  Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.

Authors:  J H Sher; A Stracher; S A Shafiq; J Hardy-Stashin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Immunoblot analysis of sarcoplasmic calcium binding proteins in Duchenne muscular dystrophy.

Authors:  I Niebrój-Dobosz; M Lukasiuk
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

6.  Erythrocyte-ghost Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Duchenne muscular dystrophy.

Authors:  M J Dunn; A H Burghes; V Dubowitz
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

7.  Increased rate of cell-substratum detachment of fibroblasts from patients with Duchenne muscular dystrophy.

Authors:  C Kent
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Creatine kinase release from regenerated muscles after eccentric contractions in rats.

Authors:  K Sakamoto; K Nosaka; S Shimegi; H Ohmori; S Katsuta
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study)

Authors:  U T Larsen; B Juhl; O Hein-Sörensen; B de Fine Olivarius
Journal:  Can J Anaesth       Date:  1989-07       Impact factor: 5.063

10.  A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblasts from patients and carriers.

Authors:  G E Jones; J A Witkowski
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.